Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports
Erastin is one of the representative agents of the first class and the prototype ferroptosis inducer that depletes GSH by irreversibly binding to SLC7A11, thus inactivating it (Dolma et al., 2003)
Losing muscle along with fat is counterproductive and potentially dangerous, especially for older adults
Cleanses well
Candidacy: Who Should Consider Each Peptide
